Lisa Miller | executive |
Richard Hawkins | executive |
John McKew | executive |
Lori Lawley | executive |
Liam Hiester | analyst |
Pisit Pitukcheewanont | executive |
Charles Duncan | analyst |
Leland Gershell | analyst |
Edward White | analyst |
Catherine Novack | analyst |
Greetings, and welcome to Lumos Pharma First Quarter 2021 Financial Results and Clinical Programs Update Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Lisa Miller, Vice President, Investor Relations. Thank you, Ms.